SMA Capital’s Amicus Therapeutics FOLD Stock Holding History

SMA Capital’s Portfolio FOLD Stock Details FOLD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-421	Closed	-$6.09K	–	146
2026 Q1	$6.09K	Buy	+421	New	+$6.04K	﹤0.01%	77

Other funds holding FOLD

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

SMA Capital's FOLD Position: Q2 2026 in Review

SMA Capital sold out of Amicus Therapeutics (FOLD) in Q2 2026, closing a stake of 421 shares — an estimated $6.09K sold.

SMA Capital first reported a position in FOLD in Q1 2026 and held it in 1 quarter. The position peaked at $6.09K in Q1 2026. 2 funds tracked by Wall St. Rank hold FOLD as of Q2 2026.

SMA Capital reported no remaining Amicus Therapeutics position as of Q2 2026 after selling out during the quarter.
SMA Capital sold 421 Amicus Therapeutics shares in Q2 2026, an estimated $6.09K.
SMA Capital first reported a position in Amicus Therapeutics in Q1 2026 and held it in 1 quarter.
SMA Capital's Amicus Therapeutics position peaked at $6.09K in Q1 2026.
2 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q2 2026.

Based on SMA Capital's 13F filing for Q2 2026, filed 14 Aug 2026.